U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323303) titled 'Real-World Study on the Burden of Hidradenitis Suppurativa' on Dec. 22, 2025.
Brief Summary: Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Hidraden...